Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Localization in Human Large Extracellular Vesicles for the EGF-CFC Founder Member CRIPTO and Its Biological and Therapeutic Implications.

Cancers·2022
Same author

Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.

Dermatologic therapy·2022
Same author

Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach.

International journal of dermatology·2022
Same author

Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study.

The Journal of dermatological treatment·2022
Same author

A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation.

International journal of dermatology·2022
Same author

A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis.

Dermatologic therapy·2022
Same journal

Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptides.

Cancer biology & therapy·2026
Same journal

<i>NSUN2</i> mediates <i>SALL2</i> m5C methylation to inhibit ferroptosis and promote breast cancer progression.

Cancer biology & therapy·2026
Same journal

Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy.

Cancer biology & therapy·2026
Same journal

ABHD17C regulates the efficacy of lenvatinib in suppressing hepatocellular carcinoma.

Cancer biology & therapy·2026
Same journal

Advances in SEC61G research: from ER translocon subunit to emerging pan-cancer oncogenic roles.

Cancer biology & therapy·2026
Same journal

Efficacy and safety profiles of CDK4/6 inhibitor in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) from the high-altitude <i>versus</i> low-altitude regions: a multi-center retrospective study.

Cancer biology & therapy·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

Generation of a Mouse Prostate Organoid-Based Model for Studying Host-Pathogen Interactions
08:05

Generation of a Mouse Prostate Organoid-Based Model for Studying Host-Pathogen Interactions

Published on: February 27, 2026

cAMP and Pyk2 interact to regulate prostate cell proliferation and function.

Annamaria Kisslinger1, Monica Cantile, Giuseppina Sparaneo

  • 1I.E.O.S-CNR, Naples, Italy.

Cancer Biology & Therapy
|December 25, 2008
PubMed
Summary
This summary is machine-generated.

Cyclic adenosine monophosphate (cAMP) and Proline-rich tyrosine kinase 2 (Pyk2) interact to regulate prostate cell growth and identity. This study reveals their functional relationship in normal and cancerous prostate cells.

More Related Videos

Measuring Cell-Edge Protrusion Dynamics during Spreading using Live-Cell Microscopy
05:50

Measuring Cell-Edge Protrusion Dynamics during Spreading using Live-Cell Microscopy

Published on: November 1, 2021

Related Experiment Videos

Last Updated: Jun 26, 2026

Generation of a Mouse Prostate Organoid-Based Model for Studying Host-Pathogen Interactions
08:05

Generation of a Mouse Prostate Organoid-Based Model for Studying Host-Pathogen Interactions

Published on: February 27, 2026

Measuring Cell-Edge Protrusion Dynamics during Spreading using Live-Cell Microscopy
05:50

Measuring Cell-Edge Protrusion Dynamics during Spreading using Live-Cell Microscopy

Published on: November 1, 2021

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Prostate Cancer Research

Background:

  • Prostate cancer cells exhibit altered proliferation and differentiation.
  • Cyclic adenosine monophosphate (cAMP) influences cell growth and differentiation.
  • Proline-rich tyrosine kinase 2 (Pyk2) expression correlates inversely with prostate cancer malignancy.

Purpose of the Study:

  • To investigate the interaction between cAMP and Pyk2 in prostate cells.
  • To understand the role of Pyk2 in cAMP-mediated signaling pathways.
  • To elucidate the impact of cAMP-Pyk2 interaction on prostate cell identity.

Main Methods:

  • Utilized EPN (normal human prostate) and EPN-PKM3 (Pyk2 kinase-negative mutant) cell lines.
  • Administered cAMP treatment to assess cellular responses.
  • Analyzed cell proliferation, Pyk2 activation, ERK1/2 and AKT1 signaling pathways.
  • Examined HOX gene expression patterns following cAMP treatment.

Main Results:

  • cAMP inhibited cell growth in both EPN and EPN-PKM3 cells.
  • cAMP activated Pyk2 but not ERK1/2 in EPN cells.
  • cAMP abolished AKT1 activation in EPN cells, but not in EPN-PKM3 cells.
  • Differential HOX gene expression was observed in EPN and EPN-PKM3 cells after cAMP treatment.

Conclusions:

  • Pyk2 and cAMP signaling pathways are functionally interconnected in prostate cells.
  • This interaction plays a crucial role in regulating prostate cell proliferation and survival.
  • The cAMP-Pyk2 interplay is essential for maintaining prostate cell identity.